Cadrenal Therapeutics, Inc. · NASDAQ:CVKD
Pham Quang X sold 12,763 Cadrenal Therapeutics, Inc. shares (Form 4)
Traded May 11 to May 28, 2026 · Filed May 29, 2026
From May 11 to May 28, 2026, Pham Quang X (Director, CEO and Chairman, 10% owner) sold 12,763 Cadrenal Therapeutics, Inc. shares at an average US$5.44 for US$69,451 under a trading plan, leaving 182,161 shares. Filed May 29, 2026 (Form 4).
- Sold
- 12,763 shares
- Price
- US$5.44 average (US$4.93 to US$5.76)
- Value
- US$69,451
- Holding after
- 182,161 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CEO and Chairman, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Sale | 6,476 | US$5.76 | 188,448 | Direct |
| May 12, 2026 | Common Stock | Sale | 3,298 | US$5.28 | 185,150 | Direct |
| May 28, 2026 | Common Stock | Sale | 2,989 | US$4.93 | 182,161 | Direct |
Source
Related
- Cadrenal Therapeutics, Inc.
- Pham Quang X
- Cadrenal Therapeutics, Inc. shareholders
- Form 4 · Pham Quang X · Jul 1, 2026
- Form 4 · Pham Quang X · Jun 26, 2026
- Form 4 · Pham Quang X · Jun 24, 2026
- Form 4 · Pham Quang X · Jun 18, 2026
- Form 4 · Pham Quang X · Jun 15, 2026
- Schedule 13G · PNC Financial Services Group, Inc. · Aug 7, 2026
- Form 4 · Pham Quang X · Jun 10, 2026
- Form 4 · Pham Quang X · Jun 5, 2026
- Form 4 · Pham Quang X · Jun 2, 2026
- Form 4 · Pham Quang X · May 26, 2026